Published in Am J Hum Genet on July 01, 1999
Benign fibro-osseous lesions of the craniofacial complex. A review. Head Neck Pathol (2008) 2.69
Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. Cell (2011) 2.34
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest (2008) 2.29
Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet (2001) 1.81
Cherubism: best clinical practice. Orphanet J Rare Dis (2012) 1.42
The diagnosis and management of giant cell lesions of the jaws. Ann Maxillofac Surg (2012) 1.06
A novel mutation in the SH3BP2 gene causes cherubism: case report. BMC Med Genet (2006) 0.97
The role of SH3BP2 in the pathophysiology of cherubism. Orphanet J Rare Dis (2012) 0.95
Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: a previously undescribed association of findings. Skeletal Radiol (2005) 0.90
Radiographic, CT and MRI features of cherubism. Pediatr Radiol (2006) 0.90
Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss. J Bone Miner Res (2014) 0.88
[Clinical and molecular genetic observations on families with cherubism over three generations]. Mund Kiefer Gesichtschir (2003) 0.85
Autoinflammatory bone diseases. Rheum Dis Clin North Am (2013) 0.84
Cherubism: Report of a case. Contemp Clin Dent (2013) 0.84
Clinical and surgical management of an aggressive cherubism treated with autogenous bone graft and calcitonin. ISRN Dent (2010) 0.83
A possible case of cherubism in a 17th-century Korean mummy. PLoS One (2014) 0.81
SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss. J Bone Miner Res (2014) 0.79
Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice. Arthritis Rheumatol (2015) 0.77
Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease. Head Face Med (2013) 0.77
Gene hunting in autoinflammation. Clin Transl Allergy (2013) 0.77
Fibrous dysplasia and cherubism. Indian J Plast Surg (2016) 0.75
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet (1985) 87.59
Sequential tests for the detection of linkage. Am J Hum Genet (1955) 43.74
A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (1996) 27.61
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A (1998) 12.61
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature (1997) 8.59
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell (1994) 5.96
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature (1994) 4.04
TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med (1997) 3.59
Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat Genet (1993) 3.49
Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet (1995) 2.51
A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet (1995) 2.30
Gingival fibromatosis combined with cherubism. Oral Surg Oral Med Oral Pathol (1967) 2.18
Noonan-like/multiple giant cell lesion syndrome. Am J Med Genet (1991) 1.63
Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet (1994) 1.58
Cherubism: diagnosis, treatment, and comparison with central giant cell granulomas and giant cell tumors. Oral Surg Oral Med Oral Pathol (1992) 1.30
Spontaneous deletion in the FMR1 gene in a patient with fragile X syndrome and cherubism. Hum Mol Genet (1995) 1.27
Cherubism: a report on three cases. Br J Oral Surg (1978) 1.11
Cherubism, gingival fibromatosis, epilepsy, and mental deficiency (Ramon syndrome) with juvenile rheumatoid arthritis. Am J Med Genet (1986) 1.06
The Noonan syndrome/cherubism association. Oral Surg Oral Med Oral Pathol (1989) 1.02
Cherubism--hereditary fibrous dysplasia of the jaws. Roentgenographic features. Am J Roentgenol Radium Ther Nucl Med (1969) 0.92
Cherubism. J Otolaryngol (1992) 0.91
Cherubism: report of a case showing regression without treatment. J Oral Maxillofac Surg (1992) 0.86
A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia. Am J Med Genet (1995) 0.84
Cherubism involving a mother and daughter: case reports and review of the literature. J Oral Maxillofac Surg (1991) 0.83
Retinal changes and tumorigenesis in Ramon syndrome: follow-up of a Brazilian family. Am J Med Genet (1998) 0.81
Construction of cosmid contigs and high-resolution restriction mapping of the Huntington disease region of human chromosome 4. Hum Mol Genet (1993) 0.81
Gene for autosomal dominant congenital stationary night blindness maps to the same region as the gene for the beta-subunit of the rod photoreceptor cGMP phosphodiesterase (PDEB) in chromosome 4p16.3. Hum Mol Genet (1994) 0.80
[Cherubism: regression of the lesions and spontaneous bone regeneration]. Rev Stomatol Chir Maxillofac (1996) 0.79
Idiopathic tooth extrusion. Oral Surg Oral Med Oral Pathol (1962) 0.79
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell (1997) 13.53
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science (1996) 5.13
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell (1996) 5.10
Malate Synthesis in Crassulacean Leaves. I. The Distribution of C in Malate of Leaves Exposed to CO(2) in the Dark. Plant Physiol (1958) 3.94
Two improved methods for preparing ferritin-protein conjugates for electron microscopy. J Cell Biol (1975) 3.81
Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet (2000) 3.64
Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil (1968) 3.38
Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet (1999) 3.24
Antagonistic interactions between FGF and BMP signaling pathways: a mechanism for positioning the sites of tooth formation. Cell (1997) 3.08
Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet (2000) 3.06
Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst (2001) 2.44
Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet (2001) 2.43
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28
Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J (2000) 2.24
Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev (2001) 2.20
Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest (2001) 2.20
A single and early migration for the peopling of the Americas supported by mitochondrial DNA sequence data. Proc Natl Acad Sci U S A (1997) 2.15
The development of the mouse ovary from birth to maturity. Acta Endocrinol (Copenh) (1969) 2.02
Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci U S A (1994) 1.96
Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr (1993) 1.96
I. Demographic data on two additional villages: Genetic structure of the tribe. Am J Hum Genet (1967) 1.95
Kidney size in childhood. Sonographical growth charts for kidney length and volume. Pediatr Radiol (1985) 1.92
Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J (1998) 1.91
Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet (1996) 1.89
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet (1994) 1.83
Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet (2001) 1.81
A transport form of collagen from embryonic tendon: electron microscopic demonstration of an NH 2 -terminal extension and evidence suggesting the presence of cystine in the molecule (chick embryo-tropocollagen-gel filtration). Proc Natl Acad Sci U S A (1972) 1.79
Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc Natl Acad Sci U S A (1997) 1.78
A nonsense mutation in MSX1 causes Witkop syndrome. Am J Hum Genet (2001) 1.74
Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett (2000) 1.72
The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem (1995) 1.70
Collagen fibril formation during embryogenesis. Proc Natl Acad Sci U S A (1983) 1.68
A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet (1993) 1.67
Hepatitis B in chronic kidney disease: moving toward effective prevention. Kidney Int (2008) 1.66
The structure of type IX collagen. J Biol Chem (1985) 1.66
Osteoarthritis associated with mild chondrodysplasia in transgenic mice expressing alpha 1(IX) collagen chains with a central deletion. Proc Natl Acad Sci U S A (1993) 1.66
Direct medical costs for surgical and medical treatment of condylomata acuminata. Arch Dermatol (2001) 1.65
Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci U S A (1995) 1.63
Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc Natl Acad Sci U S A (1994) 1.61
Tretinoin emollient cream: a new therapy for photodamaged skin. J Am Acad Dermatol (1992) 1.59
Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat Biotechnol (2001) 1.59
Osteoarthritis-like changes and decreased mechanical function of articular cartilage in the joints of mice with the chondrodysplasia gene (cho). Arthritis Rheum (2003) 1.58
Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function. J Cell Biol (1997) 1.55
The developmentally regulated type X collagen gene contains a long open reading frame without introns. J Biol Chem (1986) 1.55
Further studies on the Xavante Indians. X. Some hypotheses-generalizations resulting from these studies. Am J Hum Genet (1967) 1.55
Cyclosporine as maintenance therapy in patients with severe psoriasis. J Am Acad Dermatol (1997) 1.51
FACIT collagens: diverse molecular bridges in extracellular matrices. Trends Biochem Sci (1991) 1.50
Pathogenesis of osteoarthritis-like changes in the joints of mice deficient in type IX collagen. Arthritis Rheum (2006) 1.49
Genetic studies on the Ticuna, an enigmatic tribe of Central Amazonas. Ann Hum Genet (1980) 1.49
Nucleotide sequence of a collagen cDNA-fragment coding for the carboxyl end of pro alpha 1(I)-chains. FEBS Lett (1980) 1.48
A mutation in the gene encoding the alpha 2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nat Genet (1996) 1.47
Synthesis and characterization of cDNA encoding a cartilage-specific short collagen. Proc Natl Acad Sci U S A (1984) 1.46
Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics (1994) 1.44
Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition. Nature (1993) 1.44
The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci U S A (1998) 1.43
Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. Hum Mol Genet (1995) 1.42
Identification of the putative mammalian orthologue of Sec31P, a component of the COPII coat. J Cell Sci (1999) 1.42
Ferritin-conjugated antibodies used for labeling of organelles involved in the cellular synthesis and transport of procollagen. Proc Natl Acad Sci U S A (1974) 1.42
Collagen synthesis: localization of prolyl hydroxylase in tendon cells detected with ferritin-labeled antibodies. Science (1973) 1.41
[Passive smoking. Concentrations of smoke constituents in the air of large and small rooms as a function of number of cigarettes smoked and time]. Int Arch Arbeitsmed (1972) 1.41
A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. J Thorac Cardiovasc Surg (1996) 1.41
Human serum albumin: twenty-three genetic variants and their population distribution. Ann Hum Genet (1973) 1.40
Individual differences in pediatric cancer patients' reactions to invasive medical procedures: a repeated measures analysis. Pediatr Hematol Oncol (1994) 1.40
Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J (1997) 1.39
Diversity and age of the four major mtDNA haplogroups, and their implications for the peopling of the New World. Am J Hum Genet (1997) 1.39
Further studies on the Xavante Indians. 3. Blood groups and ABH-Lea secretor types in the Simões Lopes and São Marcos Xavantes. Am J Hum Genet (1967) 1.39
[What is the recurrence rate for Basedow's disease treated with thyrostatic agents. Answers from a prospective study]. Schweiz Med Wochenschr (1990) 1.39
Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics (1994) 1.38
Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells (2005) 1.38
Evidence for heterosis in the HLA system. Am J Hum Genet (1981) 1.37
A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22. Am J Hum Genet (1999) 1.37
Development and tissue origins of the mammalian cranial base. Dev Biol (2008) 1.36
Type XII collagen: distinct extracellular matrix component discovered by cDNA cloning. Proc Natl Acad Sci U S A (1987) 1.35
Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum Mol Genet (1998) 1.35
Origin of follicle cells in the infant mouse ovary. Fertil Steril (1967) 1.34
Enzyme-linked immunosorbent assay for detection of T-2 toxin. Hoppe Seylers Z Physiol Chem (1982) 1.33
Basement membrane assembly and differentiation of cultured corneal cells: importance of culture environment and endothelial cell interaction. Exp Cell Res (1994) 1.33
Differential localization of mRNAs of collagen types I and II in chick fibroblasts, chondrocytes, and corneal cells by in situ hybridization using cDNA probes. J Cell Biol (1986) 1.32
Serum proteins, hemoglobins and erythrocyte enzymes of Brazilian Cayapo Indians. Hum Biol (1972) 1.31
Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J (1998) 1.31
Clinical genetics of familial keloids. Arch Dermatol (2001) 1.29
VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis. Mol Genet Metab (2006) 1.29